Literature DB >> 22610284

Disease caused by non-tuberculous mycobacteria: diagnostic procedures and treatment evaluation in the North of Buenos Aires Province.

Belén Imperiale1, Martín Zumárraga, Andrea Gioffré, Beatriz Di Giulio, Angel Cataldi, Nora Morcillo.   

Abstract

Non-tuberculous mycobacteria (NTM) have emerged as pathogens frequently associated to HIV co-infection. The aims of this study were to describe the clinical importance of NTM in patients from the North of Buenos Aires Province and the drug-susceptibility patterns in relation with the therapy used. A total of 23,624 clinical specimens were investigated during the period 2004-2010. Ziehl-Neelsen stain and cultures were used for diagnosis. Molecular and biochemical tests were performed to identify the mycobacteria. TB and mycobacterioses cases were 2 118 and 108 respectively. Sixteen NTM species were found: Mycobacterium avium and Mycobacterium intracellulare as the main causative agents. Infections produced by more than one species at the same time were confirmed (4 cases). Macrolides and fluoroquinolones were the most active in vitro drugs. Treatment evaluation showed that 68.0 % of the cases completed the therapy, 20 % died; and 12 % were relapses. The cases in which the treatment outcome was evaluated received an individual tailor-made therapeutic scheme including those drugs showing in vitro activity and presumed in vivo usefulness. More than a quarter of the patients had HIV co-infection and the majority of the deaths were associated with this co-infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22610284     DOI: 10.1590/S0325-75412012000100002

Source DB:  PubMed          Journal:  Rev Argent Microbiol        ISSN: 0325-7541            Impact factor:   1.852


  7 in total

Review 1.  Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.

Authors:  D Rebecca Prevots; Theodore K Marras
Journal:  Clin Chest Med       Date:  2014-11-06       Impact factor: 2.878

2.  Genetic diversity of Mycobacterium avium complex strains isolated in Argentina by MIRU-VNTR.

Authors:  B R Imperiale; R D Moyano; A B DI Giulio; M A Romero; M F Alvarado Pinedo; M P Santangelo; G E Travería; N S Morcillo; M I Romano
Journal:  Epidemiol Infect       Date:  2017-02-07       Impact factor: 4.434

3.  Mycobacterium avium Subsp. avium infection in four veal calves: differentiation from intestinal tuberculosis.

Authors:  Christine Goepfert; Nadine Regenscheit; Vanessa Schumacher; Simone Roos; Christophe Rossier; Corinne Baehler; Sarah Schmitt; Horst Posthaus
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

4.  Identification of Species of Nontuberculous Mycobacteria Clinical Isolates from 8 Provinces of China.

Authors:  Haican Liu; Lulu Lian; Yi Jiang; Mingxiang Huang; Yunhong Tan; Xiuqin Zhao; Jingrui Zhang; Qin Yu; Jiao Liu; Haiyan Dong; Bing Lu; Yimou Wu; Kanglin Wan
Journal:  Biomed Res Int       Date:  2016-11-02       Impact factor: 3.411

5.  Epidemiology of infection by pulmonary non-tuberculous mycobacteria in French Guiana 2008-2018.

Authors:  Milène Chaptal; Claire Andrejak; Timothée Bonifay; Emmanuel Beillard; Geneviève Guillot; Stéphanie Guyomard-Rabenirina; Magalie Demar; Sabine Trombert-Paolantoni; Veronique Jacomo; Emilie Mosnier; Nicolas Veziris; Felix Djossou; Loïc Epelboin
Journal:  PLoS Negl Trop Dis       Date:  2022-09-09

6.  Tuberculosis in swine co-infected with Mycobacterium avium subsp. hominissuis and Mycobacterium bovis in a cluster from Argentina.

Authors:  S Barandiaran; A M Pérez; A K Gioffré; M Martínez Vivot; A A Cataldi; M J Zumárraga
Journal:  Epidemiol Infect       Date:  2014-12-12       Impact factor: 4.434

7.  Characterization of a Mycobacterium avium subsp. avium operon associated with virulence and drug detoxification.

Authors:  Mariana Noelia Viale; Kun Taek Park; Belén Imperiale; Andrea Karina Gioffre; María Alejandra Colombatti Olivieri; Roberto Damián Moyano; Nora Morcillo; María de la Paz Santangelo; William Davis; María Isabel Romano
Journal:  Biomed Res Int       Date:  2014-05-20       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.